United States · FDA National Drug Code directory
RISPERIDONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-167_95217dea-1f5b-4645-b55f-09a5d0e6960e
- Product NDC
- 65862-167
- Form
- SOLUTION
- Composition / generic term
- RISPERIDONE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190325
- Source listing expiry
- 20261231
Source-listed ingredients
- RISPERIDONE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (65862-167-01) / 30 mL in 1 BOTTLE · 65862-167-01
- 1 BOTTLE, GLASS in 1 CARTON (65862-167-30) / 30 mL in 1 BOTTLE, GLASS · 65862-167-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →